← Leaderboards
Bethany Lynn Niell
H. Lee Moffitt Cancer Ctr & Res Inst
$1,123,018
Attributed
$3,369,053
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $699.1K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,369,053 · 1
By mechanism
R01$3,369,053 · 1
Top collaborators
- Mehdi Damaghi5 shared
- Natarajan Raghunand4 shared
- Robert J Gillies1 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Mehdi Damaghi$4,059,891
- Ariosto S Siqueira Silva$1,904,085
- Natarajan Raghunand$3,068,009
- Marie Catherine Lee$406,943
- Susan T Vadaparampil$11,375,059
Others in their field
Other Emerging Leaders on “Core Biopsy”
- Todd Levine · Cnd Life Sciences, Inc.$5,408,271
- Jill Lebov · Research Triangle Institute$3,680,797
- Ann K Avery · Case Western Reserve University$3,647,832
- Yun Jiang · University Of Michigan At Ann Arbor$3,177,909
- Carolyn Glass · Duke University$3,115,222
- Francesca E. Duncan · Northwestern University At Chicago$3,033,904
Research focus
Core BiopsyAdjuvant TherapyAcidosisContrast EnhancedAreaAttentionAdjuvantAdvanced AnalyticsAntibodiesConsentBiological MarkersBiopsyBreastBreast CarcinogenesisAxillaBreast MalignanciesCancer CareCarcinomaCellsBasic ScienceBiochemicalClinical TrialsCohortDeep Learning
Grant awards (5)
Radiomics and Pathomics to predict upstaging of DCIS$682,707
R01 · FY2025 · CA · contact PI
Radiomics and Pathomics to predict upstaging of DCIS$648,573
R01 · FY2024 · CA · contact PI
Radiomics and Pathomics to predict upstaging of DCIS$669,313
R01 · FY2023 · CA · contact PI
Radiomics and Pathomics to predict upstaging of DCIS$669,313
R01 · FY2022 · CA · contact PI
Radiomics and Pathomics to predict upstaging of DCIS$699,147
R01 · FY2021 · CA · contact PI